Literature DB >> 23769882

Oxaliplatin-induced acquired long QT syndrome with torsades de pointes and myocardial injury in a patient with dilated cardiomyopathy and rectal cancer.

Rei-Yeuh Chang1, Ming-Yang Lee, Chung-Ben Kan, Wei-Pang Hsu, Pei-Ching Hsiao.   

Abstract

A 67-year-old woman presented with a history of dilated cardiomyopathy with congestive heart failure since 2003, who subsequently developed lower rectal cancer (adenocarcinoma) with liver, bone, and lymph node metastasis. Abdominoperineal resection and hepatectomy were performed. The patient received two rounds of intravenous chemotherapy, including 12 and six courses of FOLFOX4 (5-fluorouracil, leucovorin, and oxaliplatin; 85 mg/m(2) per cycle). She underwent a third round of intravenous FOLFOX4 because of tumor progression. During the 21(st) course of FOLFOX4 regimen, the patient developed ST segment depression in lead II and prolongation of QT interval with polymorphic ventricular tachycardia, torsades de pointes right after the start of oxaliplatin infusion. Immediate defibrillation and cardiopulmonary resuscitation were administered, and the patient regained spontaneous circulation and consciousness. Twelve-lead electrocardiogram showed ST segment elevation in III, aVF, and ST segment depression in V4-6 after resuscitation. To our knowledge, prolongation of QT interval with torsades de pointes and coronary spasm with myocardial injury that were stabilized in one patient following oxaliplatin infusion has not been reported. We present a patient with these rare complications.
Copyright © 2013. Published by Elsevier B.V.

Entities:  

Keywords:  coronary vasospasm; hypersensitivity; long QT syndrome; oxaliplatin; torsades de pointes

Mesh:

Substances:

Year:  2013        PMID: 23769882     DOI: 10.1016/j.jcma.2013.05.001

Source DB:  PubMed          Journal:  J Chin Med Assoc        ISSN: 1726-4901            Impact factor:   2.743


  4 in total

1.  QT interval prolongation and torsades de pointes with oxaliplatin.

Authors:  Jules C Hancox; Rachel E Caves; Stéphanie C M Choisy; Andrew F James
Journal:  Ther Adv Drug Saf       Date:  2016-11-15

2.  Potential Drug Interactions Between Psychotropics and Intravenous Chemotherapeutics Used by Patients With Cancer.

Authors:  Eric Diego Turossi-Amorim; Bruna Camargo; Diego Zapelini do Nascimento; Fabiana Schuelter-Trevisol
Journal:  J Pharm Technol       Date:  2022-02-18

Review 3.  Anticancer drugs-related QTc prolongation, torsade de pointes and sudden death: current evidence and future research perspectives.

Authors:  Jialin Duan; Jingwen Tao; Maocai Zhai; Chengpeng Li; Ning Zhou; Jiagao Lv; Lin Wang; Li Lin; Rong Bai
Journal:  Oncotarget       Date:  2018-05-22

4.  Cause of death among patients with colorectal cancer: a population-based study in the United States.

Authors:  Jiayuan Chen; Yongqiang Zheng; Haihong Wang; Dejun Zhang; Lei Zhao; Dandan Yu; Zhenyu Lin; Tao Zhang
Journal:  Aging (Albany NY)       Date:  2020-11-28       Impact factor: 5.682

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.